76 reports

  • RHEUMATOID ARTHRITIS

It causes chronic inflammation of any part or the entire gastrointestinal tract.

  • Arthritis
  • Managed Care
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • CHALLENGES

There are various side effects associated with the use of glucosamine and chondroitin, which include nausea, diarrhea, and gastrointestinal.

  • Arthritis
  • North America
  • United States
  • World
  • Koninklijke DSM N.V.

We are one of the nation' s Top ## health systems.

  • Managed Care
  • United States
  • Company
  • Supply
  • GlobalData's company

CHAPTER VI MARKETING STRATEGIES ##.

  • Arthritis
  • Managed Care
  • China
  • Demand
  • Yunnan Baiyao Group Co., Ltd.

THIS FURTHER ALLEVIATES PRURITUS, URTICARIA, ANGIOEDEMA AND RELIEVES GASTROINTESTINAL AND GENITOURINARY SYMPTOMS ASSOCIATED WITH ANAPHYLAXIS.

  • Arthritis
  • Neurological Disorder
  • World
  • Forecast
  • Antares Pharma, Inc.
  • Market drivers

The key single-injection cycle products are ORTHOVISC, Genvisc ##, Gel-One, Hylan GF-##, and Synvisc-One.

  • Arthritis
  • Anika Therapeutics, Inc.
  • Ferring International Center S.A.
  • Sanofi S.A.
  • Seikagaku Corporation

Shanghai No. ## Biochemical Pharmaceutical Co., Ltd.

  • Arthritis
  • Managed Care
  • China
  • Bayer AG
  • Pfizer Inc.

Journal of Autoimmunity; ##(##): ##-##.

  • Arthritis
  • Japan
  • Spain
  • United States
  • Forecast
  • Opportunities for research in osteoarthritis
  • Vendor landscape

DONULIDE IS NOT RECOMMENDED FOR PATIENTS WITH GASTROINTESTINAL BLEEDING, ULCER, AND HYPERSENSITIVITY.

  • Arthritis
  • Managed Care
  • World
  • Novartis AG
  • Pfizer Inc.

Table ##: The U. S.

  • Arthritis
  • United States
  • Anika Therapeutics, Inc.
  • Sanofi S.A.
  • Zimmer Biomet Holdings, Inc.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation
  • THERAPEUTIC INTERVENTIONS FOR RHEUMATOID ARTHRITIS: MARKETED CORTICOSTEROIDS

DARWIN ## ##. ##. ##. ##. ##.

  • Arthritis
  • North America
  • United States
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • 18.2 Market Share Analysis 2014

Drivers and their Impact Impact on Key End-User Category Patients Driver Increase in Elderly Population High Prevalence of Osteoarthritis Unmet Medical Needs Growing Obese Population Hospitals Low Low ## ## ## ## ## High Low ## ## ## ## ## High Pharmaceutical Stores Low High ## ## ## ##

  • Arthritis
  • Abbott Laboratories, Inc.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.

Rheumatoid arthritis

4546 5000 3864
  • PREVALENCE OF SELECTED CO-MORBIDITIES REPORTED IN THE INTERNATIONAL COMORA STUDY, BY REGION, 2014
  • RHEUMATOID ARTHRITIS PATIENTS RECEIVING TRADITIONAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY COUNTRY AND SEVERITY (%)

Side effects include gastrointestinal bleeding, and increased blood pressure particularly in hypertensive patients (van Laar, 2012).

  • Arthritis
  • Managed Care
  • Japan
  • United States
  • Pfizer Inc.

Crohn' s disease is an inflammatory bowel disease that causes inflammation in the digestive or gastrointestinal tract.

  • Arthritis
  • Managed Care
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee (GIDAC) meeting.

  • Arthritis
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.
  • FRESENIUS MEDICAL CARE AG & CO KGAA, DEALS BY THERAPY AREA, 2012 TO YTD 2018

DIALYSIS TREATMENTS INCREASED BY ##%.

  • Managed Care
  • Australia
  • United States
  • Company Financials
  • Fresenius Group

On July ##, 2018, the product-specific Q code for ZILRETTA took effect.

  • Arthritis
  • Therapy
  • United States
  • Corporate Finance
  • Flexion Therapeutics, Inc.
  • Mayo Foundation for Medical Education and Research, Deals By Therapy Area, 2011 to YTD 2017

Deal Rationale Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products.

  • Arthritis
  • Clinic
  • Managed Care
  • United States
  • GlobalData's company

Andrew Hendifar, the Study s Principle Investigator, Medical Oncology lead for the Gastrointestinal Disease Research Group and Co-Director of Pancreas Oncology at Cedars-Sinai.

  • Arthritis
  • Chronic Disease
  • Managed Care
  • United States
  • Product Initiative
  • OSTEOARTHRITIS - PIPELINE BY K-STEMCELL CO LTD, H1 2018
  • OSTEOARTHRITIS - PIPELINE BY INTERNATIONAL STEM CELL CORP, H1 2018

The company offers APIs in the therapeutic areas of antibiotic, oncology, cardiovascular, urology, gastrointestinal, antiviral and respiratory, among others.

  • Arthritis
  • Cell Therapy
  • United States
  • Product Initiative
  • Amgen Inc.
  • SMALL MOLECULES TO INHIBIT RIP2 FOR POLYARTHRITIS, GASTROINTESTINAL DISORDERS AND RHEUMATOID ARTHRITIS - DRUG PROFILE

Crohn’s Disease (Regional Enteritis) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Crohn’s Disease (Regional Enteritis) - Pipeline Review, H1 2018, provides an overview of the Crohn’s Disease (Regional Enteritis) (Gastrointestinal)...

  • Arthritis
  • Digestive System Disorder
  • Managed Care
  • United States
  • Product Initiative

Q. ##.

  • Arthritis
  • Managed Care
  • North America
  • United States
  • Thermo Fisher Scientific, Inc.
  • FEB 01, 2017: MIV-711 OSTEOARTHRITIS TRIAL: SUCCESSFUL FOURTH INDEPENDENT REVIEW OF SAFETY DATA ENABLES TRIAL CONTINUATION WITHOUT ANY MODIFICATIONS
  • Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC 3.4.22.38) - Product Development Milestones

The molecules developed by companies in Phase II, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Arthritis
  • United States
  • World
  • Product Initiative
  • Medivir UK Ltd.
  • ANTISENSE RNAI OLIGONUCLEOTIDE FOR ARTHRITIS AND GASTROINTESTINAL DISORDERS - DRUG PROFILE

Inflammatory Bowel Disease - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H2 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Inflammatory...

  • Arthritis
  • Autoimmune Disease
  • Managed Care
  • Research And Development
  • Pfizer Inc.
  • SMALL MOLECULES TO INHIBIT RIP2 FOR POLYARTHRITIS, GASTROINTESTINAL DISORDERS AND RHEUMATOID ARTHRITIS - DRUG PROFILE
  • RHEUMATOID ARTHRITIS - PIPELINE BY ONCODESIGN SA, H2 2017

Rheumatoid Arthritis - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H2 2017, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape. Rheumatoid arthritis...

  • Arthritis
  • Managed Care
  • Therapy
  • United States
  • Pfizer Inc.
  • DIMETHYL FUMARATE DR - DRUG PROFILE
  • DIMETHYL FUMARATE DR - DRUG PROFILE

Key GI symptoms, including nausea, vomiting, upper and lower abdominal pain and diarrhea, will be assessed using two patient-reported symptom rating scales: the Individual Gastrointestinal Symptom and Impact Scale (IGISIS) and the Global Gastrointestinal Symptom and Impact Scale (G

  • Arthritis
  • Cell Therapy
  • Managed Care
  • Respiratory Monitoring
  • Anavex Life Sciences Corp.

Subjects will be allocated to each treatment sequence in a ##:## ratio.

  • Arthritis
  • Pain Relief
  • Research And Development
  • Therapy
  • Flex Pharma, Inc.
  • BARICITINIB - DRUG PROFILE

No grade ## gastrointestinal adverse events were reported.

  • Arthritis
  • Cancer
  • Pharmaceutical
  • Therapy
  • Incyte Corporation

It targets JAK ##.

  • Arthritis
  • Digestive System Disorder
  • Company
  • Product Initiative
  • Galapagos NV